Inyx, Inc. (IYXI)

Market Cap	53.00
Revenue (ttm)	85.04M +201.2%
Net Income	-37.13M
EPS	-0.79
Shares Out	53.11M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,425
Open	0.000001
Previous Close	0.000001
Day's Range	0.000001 - 0.000001
52-Week Range	0.000001 - 0.000001
Beta	-116.39
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Inyx, Inc.

Inyx, Inc., through its wholly-owned subsidiaries, operates as a specialty pharmaceutical company in the United States, Canada, and Europe. It develops and manufactures prescription and over-the-counter pharmaceutical products. The company manufactures hydrocarbon aerosols, a delivery system for dermatological and topical drug applications; metered dose inhalers that are used for respiratory conditions; dry powdered inhalers used for respiratory ailments; metered dose nasal and throat pumps, and sprays; and sterile salines and injectables. It f...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2000
• Employees: 572
• Stock Exchange: OTCMKTS
• Ticker Symbol: IYXI

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 10, 2026

Data Sources Report a data error